These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12575942)

  • 1. Alternative conformations of HIV-1 V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity.
    Sharon M; Kessler N; Levy R; Zolla-Pazner S; Görlach M; Anglister J
    Structure; 2003 Feb; 11(2):225-36. PubMed ID: 12575942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
    Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies.
    Mor A; Segal E; Mester B; Arshava B; Rosen O; Ding FX; Russo J; Dafni A; Schvartzman F; Scherf T; Naider F; Anglister J
    Biochemistry; 2009 Apr; 48(15):3288-303. PubMed ID: 19281264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.
    Tugarinov V; Zvi A; Levy R; Hayek Y; Matsushita S; Anglister J
    Structure; 2000 Apr; 8(4):385-95. PubMed ID: 10801487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 peptide vaccine candidates: selecting constrained V3 peptides with highest affinity to antibody 447-52D.
    Mester B; Manor R; Mor A; Arshava B; Rosen O; Ding FX; Naider F; Anglister J
    Biochemistry; 2009 Aug; 48(33):7867-77. PubMed ID: 19552398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of retroviral envelope spikes in complex with the V3 loop antibody 447-52D on intact viruses by cryo-electron tomography.
    Dutta M; Liu J; Roux KH; Taylor KA
    J Virol; 2014 Nov; 88(21):12265-75. PubMed ID: 25122783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
    Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
    Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
    PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal of the V3 loop in HIV type 1 gp120 is responsible for its conformation-dependent interaction with cell surface molecules.
    Ling H; Usami O; Xiao P; Gu HX; Hattori T
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):213-8. PubMed ID: 15018709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
    Verrier F; Borman AM; Brand D; Girard M
    AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular switch for alternative conformations of the HIV-1 V3 region: implications for phenotype conversion.
    Rosen O; Sharon M; Quadt-Akabayov SR; Anglister J
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):13950-5. PubMed ID: 16966601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of immunization on chemokines and CCR5 and CXCR4 coreceptor functions in SIV binding and chemotaxis.
    Wang Y; Tao L; Mitchell E; Bergmeier L; Doyle C; Lehner T
    Vaccine; 1999 Apr; 17(15-16):1826-36. PubMed ID: 10217580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints.
    Zvi A; Tugarinov V; Faiman GA; Horovitz A; Anglister J
    Eur J Biochem; 2000 Feb; 267(3):767-79. PubMed ID: 10651813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages.
    Rabehi L; Seddiki N; Benjouad A; Gluckman JC; Gattegno L
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1605-15. PubMed ID: 9870313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution Structure of an Antibody-Bound HIV-1(IIIB) V3 Peptide: A Cis Proline Turn Linking Two β-hairpin Strands.
    Tugarinov V; Anglister J
    J Biomol Struct Dyn; 2000; 17 Suppl 1():57-63. PubMed ID: 22607407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1.
    Zolla-Pazner S; Zhong P; Revesz K; Volsky B; Williams C; Nyambi P; Gorny MK
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1254-8. PubMed ID: 15588347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition properties of V3-specific antibodies to V3 loop peptides derived from HIV-1 gp120 presented in multiple conformations.
    Huisman JG; Carotenuto A; Labrijn AF; Papavoine CH; Laman JD; Schellekens MM; Koppelman MH; Hilbers CW
    Biochemistry; 2000 Sep; 39(35):10866-76. PubMed ID: 10978173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.